Underlying conversations at the 22nd International AIDS Conference last week was a growing realization that the fight against HIV/AIDS is in crisis, with 1.8 million new infections in 2017, spikes in key populations, and falling funding. Devex rounds up the key takeaways about the biggest concerns, and what can be done.
Officials gather in London for the first-ever summit aimed at making aid more disability-inclusive, the 22nd International AIDS Conference sounds the alarm on remaining challenges in tackling HIV/AIDS, and Ebola outbreak ends.
Around the world, men are less likely to receive diagnoses and treatments for HIV/AIDS than women and are more likely to die from the disease. A new partnership of major donors, NGOs, and pharmaceuticals aims to overcome the barriers that prevent men from accessing help.
Campaigners hijacked the opening of the 22nd International AIDS Conference to protest the presence of UNAIDS Executive Director Michel Sidibé, who has been criticized for his response to a sexual harassment scandal.
People who inject drugs are more than 20 times more likely to contract the virus than the general public — they are also one of the most marginalized groups. Naomi Burke-Shyne, deputy director of Harm Reduction International, explains.
At this week’s International AIDS Conference in Amsterdam, global health care company Abbott rolls out a new point-of-care diagnostic test for HIV and AIDS designed to work in remote and under-resourced settings. The organization's Dr. Kuku Appiah tells Devex how this has the potential to accelerate treatment, prevent transmission, monitor the emergence of drug resistance, and overall, contribute to the UNAIDS 90-90-90 goals.
Christian evangelicals played a pivotal role in building support for the historic $15 billion investment in fighting HIV and AIDS around the world. U.S. global health leaders are looking to the church again as the fight against the disease enters a new and complex phase.
Adolescent girls with HIV face unique and significant barriers to reaching their full potential. Two ICRW experts explain why girls should be a focus at this year's AIDS 2018 conference.
Leading experts warn against complacency in the fight against HIV and AIDS, as new data published ahead of the 22nd International AIDS Conference next week shows minimal progress.
PEPFAR's new strategy identifies 13 countries where it will accelerate efforts to achieve epidemic control. Nigeria, despite accounting for 9 percent of the global HIV burden, was not among them.
On PEPFAR's 15th anniversary, Devex spoke to Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, about how the initiative has transformed U.S. global health, and where it goes from here.
As PEPFAR marks its 15th anniversary, Devex spoke to Agnes Binagwaho about the program, its impacts in Rwanda, and what’s needed both in the fight against HIV and AIDS and to improve health systems.
On May 27, 2003, U.S. Congress authorized the largest-ever investment in a single disease in U.S. global health history. Fifteen years later, PEPFAR has saved millions of lives and transformed global development. But to end an epidemic, the flagship HIV/AIDS program will have to go even further — and advocates fear budget pressure could jeopardize the fight.
Speaking at a congressional hearing on USAID's $9.5 billion global health supply chain project, U.S. Ambassador Deborah Birx raised questions about how effectively the $3 billion spent on technical assistance since 2009 has been deployed.
The HIV and AIDS epidemic could become uncontained if current funding trends continue, warned one of the founding architects of the United States President’s Emergency Plan for AIDS Relief.
For the first time, the Global Fund to Fight AIDS, Tuberculosis and Malaria placed a firm deadline at the end of last December, preventing countries with unspent funds from using them in the new year. The moves aims to increase predictability of spending and enhance the impact of the fund's work, Cynthia Mwase, head of the Africa and Middle East grant management directorate for the fund, told Devex.
Diagnostic technology that allows caregivers to know the HIV status of an infant born to an HIV-positive mother in the same day has been introduced across nine sub-Saharan African countries. Early evidence shows success in putting infants on vital drugs, but adoption of this technology remains low, mostly due to a lack of political and donor support, some experts argue.
Awareness-raising activities, pre-exposure prophylaxis, sexual education — these are all well-known prevention methods when it comes to HIV. But should the global development community be considering marriage matchmaking as another? Devex reports.